Eli Lilly (LLY) shares snapped six straight days of losses as the stock closed 1.39% higher, at $812.76 on Friday. The ...

Eli Lilly (LLY) stock dropped by 0.22%, underperforming the S&P 500’s 0.49% gain. Over the past month, the stock has fallen 4 ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its ...

Bayer on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares ...

FHLC offers diversification with 368 U.S. large-cap holdings, outperforming peer funds. See why I rate the fund a buy.

Hims & Hers Health (HIMS) is an intriguing stock strategically positioned in the rapidly expanding telehealth market. However, this week’s ...

At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical ...

However, analysts believe that such levies would likely have minimal financial repercussions for drug manufacturers due to the high profit margins associated with many medications. Eli Lilly is ...

Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...